USPTO Maintains Rejection on Claims in Benitec's US Patent | GenomeWeb

Benitec said last week that the US Patent and Trademark Office has again rejected certain claims within the company's core US patent, although other claims that had previously been rejected were deemed allowable.

The patent, No. 6,573,099, covers gene-expression knockdown using DNA that transcribes double-stranded RNA, and has long been the centerpiece of the company’s intellectual property estate.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.